Most Common Side Effects Clinical trials show that the most frequently reported side effects include: Nausea Vomiting Decreased appetite Diarrhea Abdominal (stomach) pain Constipation These gastrointestinal issues happen because Ozempic slows down stomach emptying
Get Your Medicare Planner Using our planner takes the headache out of Medicare because its personalized just for you, showing you what areas you need to focus on right away, or in upcoming years, and what you can ignore

Whats Inside: 16 beautifully designed, unbranded pages A 7-day meal plan with macronutrients listed for every day (calories, protein, fat, carbs, and fiber) Simple, realistic meals that support GLP-1 medication side effects and appetite changes A printable grocery list for all 7 days Grocery shopping tips including how to substitute ingredients with ease Easy-to-follow recipes designed for real life A food journal prompt to help clients track symptoms, hunger/fullness cues, and meal satisfaction Why Dietitians Love It: Client-ready & unbranded Hand it out as-is or add your own branding Saves you time No need to create a plan from scratch for clients on GLP-1s Builds trust & value Shows clients you understand their specific needs Increases client success Helps them feel less overwhelmed and more empowered in the kitchen Who Its For: Dietitians working with clients taking medications like Ozempic, Wegovy, Mounjaro, or Zepbound Professionals seeking a starter meal plan resource to guide clients through the first week of nutrition changes on GLP-1s RDs looking for an educational and practical GLP-1 nutrition resource Make it easy for your clients to nourish themselveswithout the guesswork

GLP-1 receptor agonist medications like semaglutide mimic it: they slow gastric emptying so you feel full longer, dampen the appetite signals that drive between-meal eating, and improve the way your body handles blood sugar
Lifestyle changes including dietary modification and exercise are essential to achieving weight loss and weight maintenance
Caution is advised in patients with a history of pancreatitis, as semaglutide has been associated with an increased risk of this condition